Chargement en cours...
Infliximab is a plausible alternative for neurologic complications of Behçet disease
OBJECTIVE: We evaluated the effectiveness of infliximab in patients with neuro-Behçet syndrome for whom other immunosuppressive medications had failed. METHODS: Patients whose common immunosuppressive medications fail in recurrent neuro-Behçet syndrome need an alternative. We report our experience w...
Enregistré dans:
| Publié dans: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950829/ https://ncbi.nlm.nih.gov/pubmed/27458602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000258 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|